#begin document (en_4793.txt); part 000
en_4793.txt	0	0	The	DT	(TOP(NP*	-	-	-	-	*	(0
en_4793.txt	0	1	New	NNP	*	-	-	-	-	*	-
en_4793.txt	0	2	Pharmaceutical	NNP	*	-	-	-	-	*	-
en_4793.txt	0	3	Frontier	NNP	*))	-	-	-	-	*	0)

en_4793.txt	0	0	SINGAPORE	NNP	(TOP(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	1	–	SYM	(NP*)	-	-	-	-	*	-
en_4793.txt	0	2	It	PRP	(S(NP*)	-	-	-	-	*	(0)
en_4793.txt	0	3	has	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	4	been	VBN	(VP*	-	-	-	-	*	-
en_4793.txt	0	5	a	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	6	challenging	JJ	*	-	-	-	-	*	-
en_4793.txt	0	7	decade	NN	*)	-	-	-	-	*	-
en_4793.txt	0	8	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	9	the	DT	(NP*	-	-	-	-	*	(1
en_4793.txt	0	10	pharmaceutical	JJ	*	-	-	-	-	*	-
en_4793.txt	0	11	industry	NN	*))))))	-	-	-	-	*	1)
en_4793.txt	0	12	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	With	IN	(TOP(S(PP*	-	-	-	-	*	-
en_4793.txt	0	1	patents	NNS	(S(NP*)	-	-	-	-	*	-
en_4793.txt	0	2	expiring	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	3	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	4	high	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	5	numbers	NNS	*)))))	-	-	-	-	*	-
en_4793.txt	0	6	,	,	*	-	-	-	-	*	-
en_4793.txt	0	7	new-product	NN	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	8	pipelines	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	9	drying	VBG	(VP(VP*	-	-	-	-	*	-
en_4793.txt	0	10	up	RP	(PRT*))	-	-	-	-	*	-
en_4793.txt	0	11	,	,	*	-	-	-	-	*	-
en_4793.txt	0	12	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	13	intensifying	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	14	competition	NN	(NP*)	-	-	-	-	*	-
en_4793.txt	0	15	from	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	16	generics	NNS	(NP*	-	-	-	-	*	-
en_4793.txt	0	17	,	,	*	-	-	-	-	*	-
en_4793.txt	0	18	branded	JJ	*	-	-	-	-	*	-
en_4793.txt	0	19	pharmaceuticals	NNS	*)))))	-	-	-	-	*	-
en_4793.txt	0	20	have	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	21	been	VBN	(VP*	-	-	-	-	*	-
en_4793.txt	0	22	haemorrhaging	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	23	value	NN	(NP*))))	-	-	-	-	*	-
en_4793.txt	0	24	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	At	IN	(TOP(S(PP*	-	-	-	-	*	-
en_4793.txt	0	1	the	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	2	same	JJ	*	-	-	-	-	*	-
en_4793.txt	0	3	time	NN	*))	-	-	-	-	*	-
en_4793.txt	0	4	,	,	*	-	-	-	-	*	-
en_4793.txt	0	5	traditional	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	6	markets	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	7	are	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	8	becoming	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	9	saturated	VBN	(VP*)))	-	-	-	-	*	-
en_4793.txt	0	10	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Stark	NNP	(TOP(FRAG(NP*	-	-	-	-	*	-
en_4793.txt	0	1	realities	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	2	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	3	industrialized	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	4	countries	NNS	*))	-	-	-	-	*	-
en_4793.txt	0	5	–	SYM	(X*)	-	-	-	-	*	-
en_4793.txt	0	6	such	JJ	(PP*	-	-	-	-	*	-
en_4793.txt	0	7	as	IN	*	-	-	-	-	*	-
en_4793.txt	0	8	the	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	9	impact	NN	*)	-	-	-	-	*	-
en_4793.txt	0	10	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	11	aging	VBG	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	12	populations	NNS	(NP*)	-	-	-	-	*	-
en_4793.txt	0	13	on	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	14	tax-based	JJ	(NP(ADJP*	-	-	-	-	*	-
en_4793.txt	0	15	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	16	employer-funded	JJ	*)	-	-	-	-	*	-
en_4793.txt	0	17	health-care	NN	*	-	-	-	-	*	-
en_4793.txt	0	18	models	NNS	*)))))))	-	-	-	-	*	-
en_4793.txt	0	19	–	SYM	(X*)	-	-	-	-	*	-
en_4793.txt	0	20	are	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	21	leading	VBG	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	22	governments	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	23	to	TO	(SBAR(S(VP*	-	-	-	-	*	-
en_4793.txt	0	24	adopt	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	25	regulatory	JJ	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	26	regimes	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	27	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_4793.txt	0	28	demand	VBP	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	29	more	RBR	(NP(ADJP*	-	-	-	-	*	-
en_4793.txt	0	30	economical	JJ	*	-	-	-	-	*	-
en_4793.txt	0	31	,	,	*	-	-	-	-	*	-
en_4793.txt	0	32	value-based	JJ	*	-	-	-	-	*	-
en_4793.txt	0	33	,	,	*	-	-	-	-	*	-
en_4793.txt	0	34	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	35	transparent	JJ	*)	-	-	-	-	*	-
en_4793.txt	0	36	drug	NN	*	-	-	-	-	*	-
en_4793.txt	0	37	pricing	NN	*)))))))))))	-	-	-	-	*	-
en_4793.txt	0	38	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Under	IN	(TOP(S(PP*	-	-	-	-	*	-
en_4793.txt	0	1	these	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	2	circumstances	NNS	*))	-	-	-	-	*	-
en_4793.txt	0	3	,	,	*	-	-	-	-	*	-
en_4793.txt	0	4	emerging	VBG	(NP*	-	-	-	-	*	-
en_4793.txt	0	5	markets	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	6	present	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	7	a	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	8	new	JJ	*	-	-	-	-	*	-
en_4793.txt	0	9	frontier	NN	*))	-	-	-	-	*	-
en_4793.txt	0	10	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Originally	RB	(TOP(S(S(ADJP*	-	-	-	-	*	-
en_4793.txt	0	1	attractive	JJ	*	-	-	-	-	*	-
en_4793.txt	0	2	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	3	offering	VBG	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	4	low-cost	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	5	production	NN	*))))))	-	-	-	-	*	-
en_4793.txt	0	6	,	,	*	-	-	-	-	*	-
en_4793.txt	0	7	developing	VBG	(NP*	-	-	-	-	*	-
en_4793.txt	0	8	countries	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	9	now	RB	(VP(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	10	present	VBP	*	-	-	-	-	*	-
en_4793.txt	0	11	a	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	12	viable	JJ	*	-	-	-	-	*	-
en_4793.txt	0	13	market	NN	*)	-	-	-	-	*	-
en_4793.txt	0	14	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	15	multinational	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	16	corporations	NNS	*))))	-	-	-	-	*	-
en_4793.txt	0	17	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	(1
en_4793.txt	0	1	pharmaceutical	NN	*	-	-	-	-	*	-
en_4793.txt	0	2	industry	NN	*)	-	-	-	-	*	1)
en_4793.txt	0	3	has	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	4	been	VBN	(VP*	-	-	-	-	*	-
en_4793.txt	0	5	eyeing	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	6	this	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	7	trend	NN	*)	-	-	-	-	*	-
en_4793.txt	0	8	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	9	a	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	10	while	NN	*)))))	-	-	-	-	*	-
en_4793.txt	0	11	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	A	DT	(TOP(S(NP*	-	-	-	-	*	-
en_4793.txt	0	1	recent	JJ	*	-	-	-	-	*	-
en_4793.txt	0	2	study	NN	*)	-	-	-	-	*	-
en_4793.txt	0	3	predicts	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	4	that	IN	(SBAR*	-	-	-	-	*	-
en_4793.txt	0	5	sales	NNS	(S(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	6	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	7	17	CD	(NP(NP*	-	-	-	-	*	(2
en_4793.txt	0	8	``	``	*	-	-	-	-	*	-
en_4793.txt	0	9	pharmerging	NN	*	-	-	-	-	*	-
en_4793.txt	0	10	''	''	*	-	-	-	-	*	-
en_4793.txt	0	11	countries	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	12	–	VBN	(VP*	-	-	-	-	*	-
en_4793.txt	0	13	including	VBG	(PP*	-	-	-	-	*	-
en_4793.txt	0	14	India	NNP	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	15	,	,	*	-	-	-	-	*	-
en_4793.txt	0	16	Indonesia	NNP	(NP*)	-	-	-	-	*	(3)
en_4793.txt	0	17	,	,	*	-	-	-	-	*	-
en_4793.txt	0	18	Pakistan	NNP	(NP*)	-	-	-	-	*	-
en_4793.txt	0	19	,	,	*	-	-	-	-	*	-
en_4793.txt	0	20	Thailand	NNP	(NP*)	-	-	-	-	*	-
en_4793.txt	0	21	,	,	*	-	-	-	-	*	-
en_4793.txt	0	22	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	23	Vietnam	NNP	(NP*	-	-	-	-	*	-
en_4793.txt	0	24	–	NNP	*)))))))	-	-	-	-	*	2)
en_4793.txt	0	25	will	MD	(VP*	-	-	-	-	*	-
en_4793.txt	0	26	``	``	*	-	-	-	-	*	-
en_4793.txt	0	27	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	28	aggregate	NN	(NP*))	-	-	-	-	*	-
en_4793.txt	0	29	expand	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	30	by	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	31	$	$	(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	32	90	CD	*	-	-	-	-	*	-
en_4793.txt	0	33	billion	CD	*)))	-	-	-	-	*	-
en_4793.txt	0	34	during	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	35	2009-2013	CD	(NP*)))))))	-	-	-	-	*	-
en_4793.txt	0	36	.	.	*	-	-	-	-	*	-
en_4793.txt	0	37	''	''	*))	-	-	-	-	*	-

en_4793.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_4793.txt	0	1	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	2	many	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	3	emerging	VBG	*	-	-	-	-	*	-
en_4793.txt	0	4	economies	NNS	*))	-	-	-	-	*	-
en_4793.txt	0	5	,	,	*	-	-	-	-	*	-
en_4793.txt	0	6	a	DT	(S(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	7	large	JJ	*	-	-	-	-	*	-
en_4793.txt	0	8	proportion	NN	*)	-	-	-	-	*	-
en_4793.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	10	the	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	11	population	NN	*)))	-	-	-	-	*	-
en_4793.txt	0	12	is	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	13	poor	JJ	(ADJP*)))	-	-	-	-	*	-
en_4793.txt	0	14	,	,	*	-	-	-	-	*	-
en_4793.txt	0	15	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	16	those	DT	(S(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	17	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_4793.txt	0	18	are	VBP	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	19	not	RB	*))))	-	-	-	-	*	-
en_4793.txt	0	20	remain	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	21	vulnerable	JJ	(ADJP*	-	-	-	-	*	-
en_4793.txt	0	22	to	TO	(PP*	-	-	-	-	*	-
en_4793.txt	0	23	falling	VBG	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	24	into	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	25	poverty	NN	(NP*))	-	-	-	-	*	-
en_4793.txt	0	26	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	27	times	NNS	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	28	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	29	crisis	NN	(NP*))))))))))	-	-	-	-	*	-
en_4793.txt	0	30	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Healthcare	NNP	(TOP(S(NP*)	-	-	-	-	*	-
en_4793.txt	0	1	is	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	2	financed	VBN	(VP*	-	-	-	-	*	-
en_4793.txt	0	3	largely	RB	(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	4	out-of	FW	(X(X*	-	-	-	-	*	-
en_4793.txt	0	5	pocket	NN	*	-	-	-	-	*	-
en_4793.txt	0	6	–	SYM	(X*)	-	-	-	-	*	-
en_4793.txt	0	7	up	IN	(NP(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	8	to	TO	*	-	-	-	-	*	-
en_4793.txt	0	9	60	CD	*)	-	-	-	-	*	-
en_4793.txt	0	10	%	NN	*)	-	-	-	-	*	-
en_4793.txt	0	11	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	12	Asia	NNP	(NP*)))	-	-	-	-	*	-
en_4793.txt	0	13	–	SYM	(X*)	-	-	-	-	*	-
en_4793.txt	0	14	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	15	many	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	16	countries	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	17	shoulder	NN	*)	-	-	-	-	*	-
en_4793.txt	0	18	a	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	19	``	``	*	-	-	-	-	*	-
en_4793.txt	0	20	triple	JJ	*	-	-	-	-	*	-
en_4793.txt	0	21	disease	NN	*	-	-	-	-	*	-
en_4793.txt	0	22	burden	NN	*	-	-	-	-	*	-
en_4793.txt	0	23	''	''	*)	-	-	-	-	*	-
en_4793.txt	0	24	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	25	``	``	(NP*	-	-	-	-	*	-
en_4793.txt	0	26	old	JJ	*	-	-	-	-	*	-
en_4793.txt	0	27	''	''	*	-	-	-	-	*	-
en_4793.txt	0	28	diseases	NNS	*))))	-	-	-	-	*	-
en_4793.txt	0	29	like	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	30	tuberculosis	NN	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	31	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	32	malaria	NN	*)	-	-	-	-	*	-
en_4793.txt	0	33	,	,	*	-	-	-	-	*	-
en_4793.txt	0	34	new	JJ	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	35	infectious	JJ	*	-	-	-	-	*	-
en_4793.txt	0	36	diseases	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	37	like	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	38	Influenza	NNP	(NP*	-	-	-	-	*	-
en_4793.txt	0	39	A	NNP	*))	-	-	-	-	*	-
en_4793.txt	0	40	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_4793.txt	0	41	H1N1	NNP	(NP*)	-	-	-	-	*	-
en_4793.txt	0	42	-RRB-	-RRB-	*))	-	-	-	-	*	-
en_4793.txt	0	43	,	,	*	-	-	-	-	*	-
en_4793.txt	0	44	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	45	a	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	46	``	``	*	-	-	-	-	*	-
en_4793.txt	0	47	silent	JJ	*	-	-	-	-	*	-
en_4793.txt	0	48	pandemic	NN	*	-	-	-	-	*	-
en_4793.txt	0	49	''	''	*)	-	-	-	-	*	-
en_4793.txt	0	50	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	51	the	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	52	form	NN	*)	-	-	-	-	*	-
en_4793.txt	0	53	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	54	non-communicable	JJ	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	55	diseases	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	56	such	JJ	(PP*	-	-	-	-	*	-
en_4793.txt	0	57	as	IN	*	-	-	-	-	*	-
en_4793.txt	0	58	diabetes	NN	(NP*	-	-	-	-	*	-
en_4793.txt	0	59	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	60	cancer	NN	*)))))))))))	-	-	-	-	*	-
en_4793.txt	0	61	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	1	challenges	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	2	surrounding	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	3	access	NN	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	4	to	TO	(PP*	-	-	-	-	*	-
en_4793.txt	0	5	medicines	NNS	(NP*)))))	-	-	-	-	*	(4)
en_4793.txt	0	6	remain	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	7	critical	JJ	(UCP*	-	-	-	-	*	-
en_4793.txt	0	8	,	,	*	-	-	-	-	*	-
en_4793.txt	0	9	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	10	,	,	(PRN*	-	-	-	-	*	-
en_4793.txt	0	11	indeed	RB	(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	12	,	,	*)	-	-	-	-	*	-
en_4793.txt	0	13	relevant	JJ	(ADJP*	-	-	-	-	*	-
en_4793.txt	0	14	to	TO	(PP*	-	-	-	-	*	-
en_4793.txt	0	15	the	DT	(NP(NP*	-	-	-	-	*	(1
en_4793.txt	0	16	industry	NN	*	-	-	-	-	*	-
en_4793.txt	0	17	'	POS	*)	-	-	-	-	*	1)
en_4793.txt	0	18	s	JJ	*	-	-	-	-	*	-
en_4793.txt	0	19	business	NN	*	-	-	-	-	*	-
en_4793.txt	0	20	model	NN	*)))))	-	-	-	-	*	-
en_4793.txt	0	21	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Philanthropic	NNP	(TOP(S(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	1	approaches	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	2	to	TO	(PP*	-	-	-	-	*	-
en_4793.txt	0	3	the	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	4	problem	NN	*)))	-	-	-	-	*	-
en_4793.txt	0	5	have	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	6	achieved	VBN	(VP*	-	-	-	-	*	-
en_4793.txt	0	7	little	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	8	systemic	JJ	*	-	-	-	-	*	-
en_4793.txt	0	9	change	NN	*)))	-	-	-	-	*	-
en_4793.txt	0	10	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Drug	NN	(TOP(S(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	1	donations	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	2	by	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	3	companies	NNS	(NP*)))	-	-	-	-	*	-
en_4793.txt	0	4	have	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	5	been	VBN	(VP*	-	-	-	-	*	-
en_4793.txt	0	6	criticized	VBN	(VP*	-	-	-	-	*	-
en_4793.txt	0	7	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	8	being	VBG	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	9	mostly	RB	(ADJP*	-	-	-	-	*	-
en_4793.txt	0	10	unsustainable	JJ	*)))))))	-	-	-	-	*	-
en_4793.txt	0	11	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Often	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	1	,	,	*	-	-	-	-	*	-
en_4793.txt	0	2	the	DT	(NP*	-	-	-	-	*	(4
en_4793.txt	0	3	medicines	NNS	*)	-	-	-	-	*	4)
en_4793.txt	0	4	are	VBP	(VP(VP*	-	-	-	-	*	-
en_4793.txt	0	5	unsuitable	JJ	(ADJP(ADJP*	-	-	-	-	*	-
en_4793.txt	0	6	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	7	patients	NNS	(NP*)))	-	-	-	-	*	-
en_4793.txt	0	8	,	,	*	-	-	-	-	*	-
en_4793.txt	0	9	unfamiliar	JJ	(ADJP*	-	-	-	-	*	-
en_4793.txt	0	10	to	TO	(PP*	-	-	-	-	*	-
en_4793.txt	0	11	local	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	12	prescribers	NNS	*)))))	-	-	-	-	*	-
en_4793.txt	0	13	,	,	*	-	-	-	-	*	-
en_4793.txt	0	14	do	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	15	not	RB	*	-	-	-	-	*	-
en_4793.txt	0	16	match	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	17	national	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	18	clinical	JJ	*	-	-	-	-	*	-
en_4793.txt	0	19	guidelines	NNS	*)))	-	-	-	-	*	-
en_4793.txt	0	20	,	,	*	-	-	-	-	*	-
en_4793.txt	0	21	or	CC	*	-	-	-	-	*	-
en_4793.txt	0	22	are	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	23	near	RB	(ADJP*	-	-	-	-	*	-
en_4793.txt	0	24	expiry	JJ	*)))	-	-	-	-	*	-
en_4793.txt	0	25	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Because	IN	(TOP(S(SBAR*	-	-	-	-	*	-
en_4793.txt	0	1	supplies	NNS	(S(NP(NP*)	-	-	-	-	*	(5
en_4793.txt	0	2	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	3	donated	VBN	(NP*	-	-	-	-	*	-
en_4793.txt	0	4	medicines	NNS	*)))	-	-	-	-	*	5)
en_4793.txt	0	5	can	MD	(VP*	-	-	-	-	*	-
en_4793.txt	0	6	be	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	7	unpredictable	JJ	(ADJP*)))))	-	-	-	-	*	-
en_4793.txt	0	8	,	,	*	-	-	-	-	*	-
en_4793.txt	0	9	they	PRP	(NP*)	-	-	-	-	*	(5)
en_4793.txt	0	10	can	MD	(VP*	-	-	-	-	*	-
en_4793.txt	0	11	create	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	12	chaos	NN	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	13	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	14	the	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	15	market	NN	*)))	-	-	-	-	*	-
en_4793.txt	0	16	by	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	17	preventing	VBG	(S(VP(VP*	-	-	-	-	*	-
en_4793.txt	0	18	accurate	JJ	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	19	quantification	NN	*)	-	-	-	-	*	-
en_4793.txt	0	20	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	21	needs	NNS	(NP*))))	-	-	-	-	*	-
en_4793.txt	0	22	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	23	thus	RB	(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	24	affecting	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	25	planning	NN	(NP*)))))))	-	-	-	-	*	-
en_4793.txt	0	26	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Donated	JJ	(TOP(S(NP*	-	-	-	-	*	-
en_4793.txt	0	1	supplies	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	2	also	RB	(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	3	have	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	4	the	DT	(NP(NP*	-	-	-	-	*	(6
en_4793.txt	0	5	overarching	JJ	*	-	-	-	-	*	-
en_4793.txt	0	6	negative	JJ	*	-	-	-	-	*	-
en_4793.txt	0	7	effect	NN	*)	-	-	-	-	*	-
en_4793.txt	0	8	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	9	undermining	VBG	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	10	market	NN	(NP*	-	-	-	-	*	-
en_4793.txt	0	11	competition	NN	*)	-	-	-	-	*	-
en_4793.txt	0	12	–	SYM	(SBAR(X*)	-	-	-	-	*	-
en_4793.txt	0	13	even	RB	(S(NP*	-	-	-	-	*	-
en_4793.txt	0	14	generics	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	15	cannot	MD	(VP*	-	-	-	-	*	-
en_4793.txt	0	16	compete	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	17	with	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	18	free	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	19	medicines	NNS	*)))))))))))	-	-	-	-	*	6)
en_4793.txt	0	20	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Price	NN	(TOP(S(NP*	-	-	-	-	*	(7
en_4793.txt	0	1	discounts	NNS	*)	-	-	-	-	*	7)
en_4793.txt	0	2	have	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	3	been	VBN	(VP*	-	-	-	-	*	-
en_4793.txt	0	4	more	RBR	(ADJP*	-	-	-	-	*	-
en_4793.txt	0	5	effective	JJ	*)	-	-	-	-	*	-
en_4793.txt	0	6	,	,	*	-	-	-	-	*	-
en_4793.txt	0	7	though	IN	(SBAR*	-	-	-	-	*	-
en_4793.txt	0	8	their	PRP$	(S(NP*	-	-	-	-	*	(6|(7)
en_4793.txt	0	9	effect	NN	*)	-	-	-	-	*	6)
en_4793.txt	0	10	is	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	11	limited	VBN	(VP*	-	-	-	-	*	-
en_4793.txt	0	12	by	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	13	their	PRP$	(NP(NP(NP(NP*	-	-	-	-	*	(7)
en_4793.txt	0	14	focus	NN	*)	-	-	-	-	*	-
en_4793.txt	0	15	on	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	16	specific	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	17	high-profile	JJ	*	-	-	-	-	*	-
en_4793.txt	0	18	diseases	NNS	*)))	-	-	-	-	*	-
en_4793.txt	0	19	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	20	least	JJS	(NP(ADJP*	-	-	-	-	*	-
en_4793.txt	0	21	developed	JJ	*)	-	-	-	-	*	-
en_4793.txt	0	22	countries	NNS	*))	-	-	-	-	*	-
en_4793.txt	0	23	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_4793.txt	0	24	LDCs	NNP	(NP*)	-	-	-	-	*	(8)
en_4793.txt	0	25	-RRB-	-RRB-	*)))))))))	-	-	-	-	*	-
en_4793.txt	0	26	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Advocates	NNS	(TOP(S(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	1	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	2	improved	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	3	access	NN	*))	-	-	-	-	*	-
en_4793.txt	0	4	to	TO	(PP*	-	-	-	-	*	-
en_4793.txt	0	5	medicines	NNS	(NP*)))	-	-	-	-	*	-
en_4793.txt	0	6	have	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	7	posed	VBN	(VP*	-	-	-	-	*	-
en_4793.txt	0	8	three	CD	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	9	demands	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	10	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	11	the	DT	(NP*	-	-	-	-	*	(1
en_4793.txt	0	12	pharmaceutical	JJ	*	-	-	-	-	*	-
en_4793.txt	0	13	industry	NN	*)))))	-	-	-	-	*	1)
en_4793.txt	0	14	:	:	*))	-	-	-	-	*	-

en_4793.txt	0	0	·	SYM	(TOP(FRAG(X*)	-	-	-	-	*	-
en_4793.txt	0	1	amp	VBD	(VP*	-	-	-	-	*	-
en_4793.txt	0	2	#	#	(NP*	-	-	-	-	*	-
en_4793.txt	0	3	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	4	;	:	*	-	-	-	-	*	-
en_4793.txt	0	5	amp	IN	(NP(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	6	#	#	*	-	-	-	-	*	-
en_4793.txt	0	7	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	8	;	:	*	-	-	-	-	*	-
en_4793.txt	0	9	amp	IN	(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	10	#	#	*	-	-	-	-	*	-
en_4793.txt	0	11	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	12	;	:	*	-	-	-	-	*	-
en_4793.txt	0	13	amp	RB	(ADVP*	-	-	-	-	*	-
en_4793.txt	0	14	#	#	(NP*	-	-	-	-	*	-
en_4793.txt	0	15	160	CD	*)))	-	-	-	-	*	-
en_4793.txt	0	16	;	:	*	-	-	-	-	*	-
en_4793.txt	0	17	amp	IN	(NP(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	18	#	#	*	-	-	-	-	*	-
en_4793.txt	0	19	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	20	;	:	*	-	-	-	-	*	-
en_4793.txt	0	21	amp	IN	(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	22	#	#	*	-	-	-	-	*	-
en_4793.txt	0	23	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	24	;	:	*	-	-	-	-	*	-
en_4793.txt	0	25	amp	RB	(ADVP*	-	-	-	-	*	-
en_4793.txt	0	26	#	#	(NP*	-	-	-	-	*	-
en_4793.txt	0	27	160	CD	*)))	-	-	-	-	*	-
en_4793.txt	0	28	;	:	*))	-	-	-	-	*	-

en_4793.txt	0	0	Transparent	CC	(TOP(FRAG*	-	-	-	-	*	-
en_4793.txt	0	1	pricing	NN	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	2	schemes	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	3	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_4793.txt	0	4	systematically	RB	(S(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	5	address	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	6	the	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	7	challenge	NN	*)	-	-	-	-	*	-
en_4793.txt	0	8	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	9	affordability	NN	(NP*)))))))	-	-	-	-	*	-
en_4793.txt	0	10	;	:	*))	-	-	-	-	*	-

en_4793.txt	0	0	·	SYM	(TOP(FRAG(X*)	-	-	-	-	*	-
en_4793.txt	0	1	amp	VBD	(VP*	-	-	-	-	*	-
en_4793.txt	0	2	#	#	(NP*	-	-	-	-	*	-
en_4793.txt	0	3	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	4	;	:	*	-	-	-	-	*	-
en_4793.txt	0	5	amp	IN	(NP(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	6	#	#	*	-	-	-	-	*	-
en_4793.txt	0	7	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	8	;	:	*	-	-	-	-	*	-
en_4793.txt	0	9	amp	IN	(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	10	#	#	*	-	-	-	-	*	-
en_4793.txt	0	11	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	12	;	:	*	-	-	-	-	*	-
en_4793.txt	0	13	amp	RB	(ADVP*	-	-	-	-	*	-
en_4793.txt	0	14	#	#	(NP*	-	-	-	-	*	-
en_4793.txt	0	15	160	CD	*)))	-	-	-	-	*	-
en_4793.txt	0	16	;	:	*	-	-	-	-	*	-
en_4793.txt	0	17	amp	IN	(NP(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	18	#	#	*	-	-	-	-	*	-
en_4793.txt	0	19	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	20	;	:	*	-	-	-	-	*	-
en_4793.txt	0	21	amp	IN	(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	22	#	#	*	-	-	-	-	*	-
en_4793.txt	0	23	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	24	;	:	*	-	-	-	-	*	-
en_4793.txt	0	25	amp	RB	(ADVP*	-	-	-	-	*	-
en_4793.txt	0	26	#	#	(NP*	-	-	-	-	*	-
en_4793.txt	0	27	160	CD	*)))	-	-	-	-	*	-
en_4793.txt	0	28	;	:	*))	-	-	-	-	*	-

en_4793.txt	0	0	Investment	NN	(TOP(NP(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	1	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	2	research	NN	(NP*	-	-	-	-	*	-
en_4793.txt	0	3	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	4	development	NN	*))	-	-	-	-	*	-
en_4793.txt	0	5	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_4793.txt	0	6	is	VBZ	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	7	relevant	JJ	(ADJP*	-	-	-	-	*	-
en_4793.txt	0	8	to	TO	(PP(PP*	-	-	-	-	*	-
en_4793.txt	0	9	the	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	10	diseases	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	11	affecting	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	12	developing	VBG	(NP*	-	-	-	-	*	-
en_4793.txt	0	13	countries	NNS	*))))	-	-	-	-	*	-
en_4793.txt	0	14	,	,	*	-	-	-	-	*	-
en_4793.txt	0	15	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	16	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	17	medicines	NNS	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	18	suitable	JJ	(ADJP*	-	-	-	-	*	-
en_4793.txt	0	19	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	20	resource-poor	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	21	contexts	NNS	*)))	-	-	-	-	*	-
en_4793.txt	0	22	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_4793.txt	0	23	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	24	example	NN	(NP*))	-	-	-	-	*	-
en_4793.txt	0	25	,	,	*	-	-	-	-	*	-
en_4793.txt	0	26	heat-stable	JJ	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	27	formulations	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	28	or	CC	*	-	-	-	-	*	-
en_4793.txt	0	29	fixed	VBN	(NP*	-	-	-	-	*	-
en_4793.txt	0	30	combination	NN	*	-	-	-	-	*	-
en_4793.txt	0	31	drugs	NNS	*))	-	-	-	-	*	-
en_4793.txt	0	32	-RRB-	-RRB-	*)))))))))	-	-	-	-	*	-
en_4793.txt	0	33	;	:	*	-	-	-	-	*	-
en_4793.txt	0	34	and	NNP	(NP*)))	-	-	-	-	*	-

en_4793.txt	0	0	·	SYM	(TOP(FRAG(X*)	-	-	-	-	*	-
en_4793.txt	0	1	amp	VBD	(VP*	-	-	-	-	*	-
en_4793.txt	0	2	#	#	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	3	160	CD	*)	-	-	-	-	*	-
en_4793.txt	0	4	;	:	*	-	-	-	-	*	-
en_4793.txt	0	5	amp	IN	(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	6	#	#	*	-	-	-	-	*	-
en_4793.txt	0	7	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	8	;	:	*	-	-	-	-	*	-
en_4793.txt	0	9	amp	IN	(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	10	#	#	*	-	-	-	-	*	-
en_4793.txt	0	11	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	12	;	:	*	-	-	-	-	*	-
en_4793.txt	0	13	amp	IN	(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	14	#	#	*	-	-	-	-	*	-
en_4793.txt	0	15	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	16	;	:	*	-	-	-	-	*	-
en_4793.txt	0	17	amp	IN	(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	18	#	#	*	-	-	-	-	*	-
en_4793.txt	0	19	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	20	;	:	*	-	-	-	-	*	-
en_4793.txt	0	21	amp	IN	(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	22	#	#	*	-	-	-	-	*	-
en_4793.txt	0	23	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	24	;	:	*	-	-	-	-	*	-
en_4793.txt	0	25	amp	IN	(NP(QP*	-	-	-	-	*	-
en_4793.txt	0	26	#	#	*	-	-	-	-	*	-
en_4793.txt	0	27	160	CD	*))	-	-	-	-	*	-
en_4793.txt	0	28	;	:	*	-	-	-	-	*	-
en_4793.txt	0	29	A	DT	(NP(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	30	flexible	JJ	*	-	-	-	-	*	-
en_4793.txt	0	31	approach	NN	*)	-	-	-	-	*	-
en_4793.txt	0	32	to	TO	(PP*	-	-	-	-	*	-
en_4793.txt	0	33	intellectual	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	34	property	NN	*))	-	-	-	-	*	-
en_4793.txt	0	35	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_4793.txt	0	36	IP	NNP	(NP*)	-	-	-	-	*	-
en_4793.txt	0	37	-RRB-	-RRB-	*))	-	-	-	-	*	-
en_4793.txt	0	38	rights	NNS	(NP*))	-	-	-	-	*	-
en_4793.txt	0	39	,	,	*)	-	-	-	-	*	-
en_4793.txt	0	40	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	41	recognition	NN	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	42	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	43	the	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	44	role	NN	*)	-	-	-	-	*	-
en_4793.txt	0	45	that	IN	(SBAR*	-	-	-	-	*	-
en_4793.txt	0	46	generics	NNS	(S(NP*)	-	-	-	-	*	-
en_4793.txt	0	47	play	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	48	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	49	vastly	RB	(S(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	50	reducing	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	51	medicine	NN	(NP*	-	-	-	-	*	-
en_4793.txt	0	52	prices	NNS	*))))))))))))	-	-	-	-	*	-
en_4793.txt	0	53	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Leading	VBG	(TOP(S(NP*	-	-	-	-	*	-
en_4793.txt	0	1	companies	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	2	are	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	3	starting	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	4	to	TO	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	5	understand	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	6	how	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_4793.txt	0	7	integrating	VBG	(S(S(VP*	-	-	-	-	*	-
en_4793.txt	0	8	these	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	9	concerns	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	10	into	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	11	core	NN	(NP*	-	-	-	-	*	-
en_4793.txt	0	12	business	NN	*	-	-	-	-	*	-
en_4793.txt	0	13	practices	NNS	*))))	-	-	-	-	*	-
en_4793.txt	0	14	may	MD	(VP*	-	-	-	-	*	-
en_4793.txt	0	15	hold	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	16	the	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	17	answer	NN	*)	-	-	-	-	*	-
en_4793.txt	0	18	to	TO	(PP*	-	-	-	-	*	-
en_4793.txt	0	19	sustainable	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	20	long-term	JJ	*	-	-	-	-	*	-
en_4793.txt	0	21	profitability	NN	*))	-	-	-	-	*	-
en_4793.txt	0	22	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	23	emerging	VBG	(NP*	-	-	-	-	*	-
en_4793.txt	0	24	markets	NNS	*)))))))))))	-	-	-	-	*	-
en_4793.txt	0	25	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Reliance	NNP	(TOP(S(NP(NP*)	-	-	-	-	*	(9
en_4793.txt	0	1	on	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	2	the	DT	(NP(NP*	-	-	-	-	*	(10
en_4793.txt	0	3	traditional	JJ	*	-	-	-	-	*	-
en_4793.txt	0	4	``	``	*	-	-	-	-	*	-
en_4793.txt	0	5	blockbuster	NN	*	-	-	-	-	*	-
en_4793.txt	0	6	''	''	*	-	-	-	-	*	-
en_4793.txt	0	7	model	NN	*)	-	-	-	-	*	10)
en_4793.txt	0	8	,	,	*	-	-	-	-	*	-
en_4793.txt	0	9	which	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_4793.txt	0	10	targets	VBZ	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	11	the	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	12	elite	NN	*))))	-	-	-	-	*	-
en_4793.txt	0	13	,	,	*)))	-	-	-	-	*	9)
en_4793.txt	0	14	is	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	15	proving	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	16	unfeasible	JJ	(ADJP*	-	-	-	-	*	-
en_4793.txt	0	17	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	18	short-sighted	JJ	*)))	-	-	-	-	*	-
en_4793.txt	0	19	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	For	IN	(TOP(S(PP*	-	-	-	-	*	-
en_4793.txt	0	1	starters	NNS	(NP*))	-	-	-	-	*	-
en_4793.txt	0	2	,	,	*	-	-	-	-	*	-
en_4793.txt	0	3	it	PRP	(NP*)	-	-	-	-	*	(9)
en_4793.txt	0	4	limits	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	5	the	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	6	size	NN	*)	-	-	-	-	*	-
en_4793.txt	0	7	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	8	the	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	9	consumer	NN	*	-	-	-	-	*	-
en_4793.txt	0	10	base	NN	*))))	-	-	-	-	*	-
en_4793.txt	0	11	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	More	RBR	(TOP(S(ADVP*	-	-	-	-	*	-
en_4793.txt	0	1	importantly	RB	*)	-	-	-	-	*	-
en_4793.txt	0	2	,	,	*	-	-	-	-	*	-
en_4793.txt	0	3	the	DT	(NP(NP(NP*	-	-	-	-	*	(10
en_4793.txt	0	4	model	NN	*	-	-	-	-	*	-
en_4793.txt	0	5	'	POS	*)	-	-	-	-	*	10)
en_4793.txt	0	6	s	JJ	*	-	-	-	-	*	-
en_4793.txt	0	7	dependence	NN	*)	-	-	-	-	*	-
en_4793.txt	0	8	on	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	9	aggressive	JJ	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	10	defense	NN	*)	-	-	-	-	*	-
en_4793.txt	0	11	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	12	patents	NNS	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	13	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	14	high	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	15	profit	NN	*	-	-	-	-	*	-
en_4793.txt	0	16	margins	NNS	*))))))	-	-	-	-	*	-
en_4793.txt	0	17	,	,	*	-	-	-	-	*	-
en_4793.txt	0	18	in	IN	(SBAR*	-	-	-	-	*	-
en_4793.txt	0	19	order	NN	*	-	-	-	-	*	-
en_4793.txt	0	20	to	TO	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	21	generate	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	22	the	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	23	all-important	JJ	*	-	-	-	-	*	-
en_4793.txt	0	24	$	$	(QP*	-	-	-	-	*	-
en_4793.txt	0	25	1	CD	*	-	-	-	-	*	-
en_4793.txt	0	26	billion	CD	*))	-	-	-	-	*	-
en_4793.txt	0	27	per	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	28	annum	NN	(NP*)))))))	-	-	-	-	*	-
en_4793.txt	0	29	,	,	*	-	-	-	-	*	-
en_4793.txt	0	30	keeps	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	31	companies	NNS	(NP*)	-	-	-	-	*	-
en_4793.txt	0	32	from	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	33	serving	VBG	(NP*	-	-	-	-	*	-
en_4793.txt	0	34	target	NN	*	-	-	-	-	*	-
en_4793.txt	0	35	markets	NNS	*))	-	-	-	-	*	-
en_4793.txt	0	36	effectively	RB	(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	37	by	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	38	providing	VBG	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	39	products	NNS	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	40	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_4793.txt	0	41	are	VBP	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	42	relevant	JJ	(ADJP*	-	-	-	-	*	-
en_4793.txt	0	43	,	,	*	-	-	-	-	*	-
en_4793.txt	0	44	affordable	JJ	*	-	-	-	-	*	-
en_4793.txt	0	45	,	,	*	-	-	-	-	*	-
en_4793.txt	0	46	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	47	accessible	JJ	*)))))))))	-	-	-	-	*	-
en_4793.txt	0	48	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Many	JJ	(TOP(S(NP*)	-	-	-	-	*	-
en_4793.txt	0	1	argue	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	2	that	IN	(SBAR*	-	-	-	-	*	-
en_4793.txt	0	3	the	DT	(S(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	4	perverse	JJ	*	-	-	-	-	*	-
en_4793.txt	0	5	incentives	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	6	created	VBN	(VP*	-	-	-	-	*	-
en_4793.txt	0	7	by	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	8	the	DT	(NP*	-	-	-	-	*	(10
en_4793.txt	0	9	blockbuster	NN	*	-	-	-	-	*	-
en_4793.txt	0	10	model	NN	*))))	-	-	-	-	*	10)
en_4793.txt	0	11	discourage	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	12	innovation	NN	(NP*)))))	-	-	-	-	*	-
en_4793.txt	0	13	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Finally	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	1	,	,	*	-	-	-	-	*	-
en_4793.txt	0	2	developing-country	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	3	governments	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	4	are	VBP	(VP(VP*	-	-	-	-	*	-
en_4793.txt	0	5	beginning	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	6	to	TO	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	7	prioritize	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	8	health	NN	(NP*	-	-	-	-	*	-
en_4793.txt	0	9	care	NN	*))))))	-	-	-	-	*	-
en_4793.txt	0	10	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	11	are	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	12	seeking	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	13	cost-efficient	JJ	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	14	outcomes	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	15	,	,	*	-	-	-	-	*	-
en_4793.txt	0	16	as	RB	(CONJP*	-	-	-	-	*	-
en_4793.txt	0	17	well	RB	*	-	-	-	-	*	-
en_4793.txt	0	18	as	IN	*)	-	-	-	-	*	-
en_4793.txt	0	19	the	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	20	means	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	21	to	TO	(SBAR(S(VP*	-	-	-	-	*	-
en_4793.txt	0	22	effectively	RB	(VP(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	23	manage	VB	*	-	-	-	-	*	-
en_4793.txt	0	24	disease	NN	(NP*	-	-	-	-	*	-
en_4793.txt	0	25	burdens	NNS	*))))))))))	-	-	-	-	*	-
en_4793.txt	0	26	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_4793.txt	0	1	these	DT	(NP*	-	-	-	-	*	(2
en_4793.txt	0	2	countries	NNS	*))	-	-	-	-	*	2)
en_4793.txt	0	3	,	,	*	-	-	-	-	*	-
en_4793.txt	0	4	building	VBG	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	5	access	NN	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	6	to	TO	(PP*	-	-	-	-	*	-
en_4793.txt	0	7	medicine	NN	(NP*)))	-	-	-	-	*	-
en_4793.txt	0	8	into	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	9	companies	NNS	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	10	'	POS	*)	-	-	-	-	*	-
en_4793.txt	0	11	core	JJ	*	-	-	-	-	*	-
en_4793.txt	0	12	business	NN	*	-	-	-	-	*	-
en_4793.txt	0	13	models	NNS	*))))	-	-	-	-	*	-
en_4793.txt	0	14	has	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	15	become	VBN	(VP*	-	-	-	-	*	-
en_4793.txt	0	16	vital	JJ	(ADJP*	-	-	-	-	*	-
en_4793.txt	0	17	to	TO	(PP*	-	-	-	-	*	-
en_4793.txt	0	18	securing	VBG	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	19	a	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	20	license	NN	*	-	-	-	-	*	-
en_4793.txt	0	21	to	TO	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	22	operate	VB	(VP*))))))))))	-	-	-	-	*	-
en_4793.txt	0	23	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	At	IN	(TOP(S(PP*	-	-	-	-	*	-
en_4793.txt	0	1	the	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	2	end	NN	*)	-	-	-	-	*	-
en_4793.txt	0	3	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	4	2008	CD	(NP*))))	-	-	-	-	*	-
en_4793.txt	0	5	,	,	*	-	-	-	-	*	-
en_4793.txt	0	6	one	CD	(NP*	-	-	-	-	*	-
en_4793.txt	0	7	company	NN	*)	-	-	-	-	*	-
en_4793.txt	0	8	attempted	VBD	(VP*	-	-	-	-	*	-
en_4793.txt	0	9	to	TO	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	10	beat	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	11	a	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	12	new	JJ	*	-	-	-	-	*	-
en_4793.txt	0	13	path	NN	*)))))	-	-	-	-	*	-
en_4793.txt	0	14	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	1	chief	JJ	*	-	-	-	-	*	-
en_4793.txt	0	2	executive	NN	*)	-	-	-	-	*	-
en_4793.txt	0	3	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	4	GlaxoSmithKline	NNP	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	5	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_4793.txt	0	6	GSK	NNP	(NP*)	-	-	-	-	*	(11)
en_4793.txt	0	7	-RRB-	-RRB-	*))))	-	-	-	-	*	-
en_4793.txt	0	8	unveiled	VBD	(VP*	-	-	-	-	*	-
en_4793.txt	0	9	a	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	10	four-point	JJ	*	-	-	-	-	*	-
en_4793.txt	0	11	plan	NN	*)	-	-	-	-	*	-
en_4793.txt	0	12	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_4793.txt	0	13	included	VBD	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	14	a	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	15	commitment	NN	*	-	-	-	-	*	-
en_4793.txt	0	16	to	TO	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	17	cap	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	18	prices	NNS	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	19	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	20	patented	JJ	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	21	medicines	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	22	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	23	LDCs	NNP	(NP*)))))))))	-	-	-	-	*	(8)
en_4793.txt	0	24	at	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	25	25	CD	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	26	%	NN	*)	-	-	-	-	*	-
en_4793.txt	0	27	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	28	the	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	29	price	NN	*))))	-	-	-	-	*	-
en_4793.txt	0	30	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	31	the	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	32	developed	VBN	*	-	-	-	-	*	-
en_4793.txt	0	33	world	NN	*)))))))	-	-	-	-	*	-
en_4793.txt	0	34	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_4793.txt	0	1	middle-income	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	2	countries	NNS	*))	-	-	-	-	*	-
en_4793.txt	0	3	,	,	*	-	-	-	-	*	-
en_4793.txt	0	4	prices	NNS	(NP*)	-	-	-	-	*	-
en_4793.txt	0	5	would	MD	(VP*	-	-	-	-	*	-
en_4793.txt	0	6	more	RBR	(VP(ADVP*	-	-	-	-	*	-
en_4793.txt	0	7	closely	RB	*)	-	-	-	-	*	-
en_4793.txt	0	8	reflect	VB	*	-	-	-	-	*	-
en_4793.txt	0	9	a	DT	(NP(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	10	country	NN	*	-	-	-	-	*	-
en_4793.txt	0	11	'	POS	*)	-	-	-	-	*	-
en_4793.txt	0	12	s	JJ	*	-	-	-	-	*	-
en_4793.txt	0	13	ability	NN	*	-	-	-	-	*	-
en_4793.txt	0	14	to	TO	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	15	pay	VB	(VP*))))	-	-	-	-	*	-
en_4793.txt	0	16	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_4793.txt	0	17	for	IN	(S(PP*	-	-	-	-	*	-
en_4793.txt	0	18	example	NN	(NP*))	-	-	-	-	*	-
en_4793.txt	0	19	,	,	*	-	-	-	-	*	-
en_4793.txt	0	20	GSK	NNP	(NP*)	-	-	-	-	*	(11)
en_4793.txt	0	21	cut	VBD	(VP(VP*	-	-	-	-	*	-
en_4793.txt	0	22	the	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	23	price	NN	*)	-	-	-	-	*	-
en_4793.txt	0	24	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	25	its	PRP$	(NP(NP*	-	-	-	-	*	(11)
en_4793.txt	0	26	cervical	JJ	*	-	-	-	-	*	-
en_4793.txt	0	27	cancer	NN	*	-	-	-	-	*	-
en_4793.txt	0	28	vaccine	NN	*)	-	-	-	-	*	-
en_4793.txt	0	29	,	,	*	-	-	-	-	*	-
en_4793.txt	0	30	Cervarix	NNP	(NP*)	-	-	-	-	*	-
en_4793.txt	0	31	,	,	*)))	-	-	-	-	*	-
en_4793.txt	0	32	by	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	33	60	CD	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	34	%	NN	*)	-	-	-	-	*	-
en_4793.txt	0	35	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	36	the	DT	(NP*	-	-	-	-	*	(12
en_4793.txt	0	37	Philippines	NNPS	*)))))	-	-	-	-	*	12)
en_4793.txt	0	38	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	39	gained	VBD	(VP*	-	-	-	-	*	-
en_4793.txt	0	40	a	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	41	14-fold	JJ	*	-	-	-	-	*	-
en_4793.txt	0	42	increase	NN	*)	-	-	-	-	*	-
en_4793.txt	0	43	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	44	volume	NN	(NP*	-	-	-	-	*	-
en_4793.txt	0	45	sales	NNS	*))))))	-	-	-	-	*	-
en_4793.txt	0	46	-RRB-	-RRB-	*))))	-	-	-	-	*	-
en_4793.txt	0	47	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Further	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	1	,	,	*	-	-	-	-	*	-
en_4793.txt	0	2	it	PRP	(NP*)	-	-	-	-	*	(11)
en_4793.txt	0	3	proposed	VBD	(VP(VP*	-	-	-	-	*	-
en_4793.txt	0	4	the	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	5	establishment	NN	*)	-	-	-	-	*	-
en_4793.txt	0	6	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	7	an	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	8	LDC	NNP	*	-	-	-	-	*	-
en_4793.txt	0	9	patent	NN	*	-	-	-	-	*	-
en_4793.txt	0	10	pool	NN	*)))	-	-	-	-	*	-
en_4793.txt	0	11	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	12	neglected	VBN	(NP*	-	-	-	-	*	-
en_4793.txt	0	13	tropical	JJ	*	-	-	-	-	*	-
en_4793.txt	0	14	diseases	NNS	*)))	-	-	-	-	*	-
en_4793.txt	0	15	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	16	donated	VBD	(VP*	-	-	-	-	*	-
en_4793.txt	0	17	to	TO	(PP*	-	-	-	-	*	-
en_4793.txt	0	18	it	PRP	(NP*))	-	-	-	-	*	(11)
en_4793.txt	0	19	13,500	CD	(NP*	-	-	-	-	*	-
en_4793.txt	0	20	compounds	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	21	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	22	malaria	NN	(NP*	-	-	-	-	*	-
en_4793.txt	0	23	vaccines	NNS	*))))	-	-	-	-	*	-
en_4793.txt	0	24	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Slowly	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	1	,	,	*	-	-	-	-	*	-
en_4793.txt	0	2	other	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	3	companies	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	4	are	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	5	following	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	6	suit	NN	(NP*)))	-	-	-	-	*	-
en_4793.txt	0	7	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Sanofi-Aventis	NNP	(TOP(S(NP*)	-	-	-	-	*	(13)
en_4793.txt	0	1	recently	RB	(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	2	announced	VBD	(VP*	-	-	-	-	*	-
en_4793.txt	0	3	that	IN	(SBAR*	-	-	-	-	*	-
en_4793.txt	0	4	it	PRP	(S(NP*)	-	-	-	-	*	(13)
en_4793.txt	0	5	would	MD	(VP*	-	-	-	-	*	-
en_4793.txt	0	6	halve	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	7	the	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	8	price	NN	*)	-	-	-	-	*	-
en_4793.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	10	its	PRP$	(NP(NP(NP*	-	-	-	-	*	(13)
en_4793.txt	0	11	diabetes	NN	*	-	-	-	-	*	-
en_4793.txt	0	12	drug	NN	*)	-	-	-	-	*	-
en_4793.txt	0	13	,	,	*	-	-	-	-	*	-
en_4793.txt	0	14	Lantus	NNP	(NP*)	-	-	-	-	*	-
en_4793.txt	0	15	,	,	*)	-	-	-	-	*	-
en_4793.txt	0	16	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	17	cancer	NN	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	18	treatment	NN	*)	-	-	-	-	*	-
en_4793.txt	0	19	,	,	*	-	-	-	-	*	-
en_4793.txt	0	20	Taxotere	NNP	(NP*)	-	-	-	-	*	-
en_4793.txt	0	21	,	,	*))))	-	-	-	-	*	-
en_4793.txt	0	22	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	23	Indonesia	NNP	(NP(NP*)	-	-	-	-	*	(3)
en_4793.txt	0	24	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	25	the	DT	(NP*	-	-	-	-	*	(12
en_4793.txt	0	26	Philippines	NNPS	*))))))))	-	-	-	-	*	12)
en_4793.txt	0	27	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	(14
en_4793.txt	0	1	Japanese	JJ	*	-	-	-	-	*	-
en_4793.txt	0	2	firm	NN	*	-	-	-	-	*	-
en_4793.txt	0	3	Eisai	NNP	*)	-	-	-	-	*	14)
en_4793.txt	0	4	dropped	VBD	(VP*	-	-	-	-	*	-
en_4793.txt	0	5	its	PRP$	(NP(NP*	-	-	-	-	*	(14)
en_4793.txt	0	6	price	NN	*)	-	-	-	-	*	-
en_4793.txt	0	7	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	8	Aricept	NNP	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	9	,	,	*	-	-	-	-	*	-
en_4793.txt	0	10	an	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	11	Alzheimer	NNP	(NP*	-	-	-	-	*	-
en_4793.txt	0	12	'	POS	*)	-	-	-	-	*	-
en_4793.txt	0	13	s	NN	*	-	-	-	-	*	-
en_4793.txt	0	14	treatment	NN	*))))	-	-	-	-	*	-
en_4793.txt	0	15	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	16	six	CD	(NP*	-	-	-	-	*	-
en_4793.txt	0	17	Asian	JJ	*	-	-	-	-	*	-
en_4793.txt	0	18	countries	NNS	*)))	-	-	-	-	*	-
en_4793.txt	0	19	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Other	JJ	(TOP(S(NP*	-	-	-	-	*	-
en_4793.txt	0	1	companies	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	2	are	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	3	experimenting	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	4	with	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	5	base-of-pyramid	JJ	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	6	models	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	7	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_4793.txt	0	8	seek	VBP	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	9	to	TO	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	10	boost	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	11	sales	NNS	(NP*)))))))))))	-	-	-	-	*	-
en_4793.txt	0	12	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Novartis	NNP	(TOP(S(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	1	'	POS	*)	-	-	-	-	*	-
en_4793.txt	0	2	s	NNP	*	-	-	-	-	*	-
en_4793.txt	0	3	Arogya	NNP	*	-	-	-	-	*	-
en_4793.txt	0	4	Parivar	NNP	*	-	-	-	-	*	-
en_4793.txt	0	5	model	NN	*)	-	-	-	-	*	-
en_4793.txt	0	6	sells	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	7	medicines	NNS	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	8	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	9	smaller	JJR	(NP(ADJP*	-	-	-	-	*	-
en_4793.txt	0	10	,	,	*	-	-	-	-	*	-
en_4793.txt	0	11	more	JJR	*)	-	-	-	-	*	-
en_4793.txt	0	12	affordable	JJ	*	-	-	-	-	*	-
en_4793.txt	0	13	package	NN	*	-	-	-	-	*	-
en_4793.txt	0	14	sizes	NNS	*))))	-	-	-	-	*	-
en_4793.txt	0	15	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	The	DT	(TOP(S(S(NP*	-	-	-	-	*	-
en_4793.txt	0	1	jury	NN	*)	-	-	-	-	*	-
en_4793.txt	0	2	is	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	3	still	RB	(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	4	out	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	5	on	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	6	whether	IN	(SBAR(SBAR*	-	-	-	-	*	-
en_4793.txt	0	7	or	CC	*	-	-	-	-	*	-
en_4793.txt	0	8	not	RB	*	-	-	-	-	*	-
en_4793.txt	0	9	these	DT	(S(NP*	-	-	-	-	*	-
en_4793.txt	0	10	new	JJ	*	-	-	-	-	*	-
en_4793.txt	0	11	approaches	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	12	deliver	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	13	systemic	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	14	change	NN	*))))	-	-	-	-	*	-
en_4793.txt	0	15	,	,	*	-	-	-	-	*	-
en_4793.txt	0	16	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	17	whether	IN	(SBAR*	-	-	-	-	*	-
en_4793.txt	0	18	companies	NNS	(S(NP*)	-	-	-	-	*	-
en_4793.txt	0	19	are	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	20	adopting	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	21	a	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	22	``	``	*	-	-	-	-	*	-
en_4793.txt	0	23	serve	VB	*	-	-	-	-	*	-
en_4793.txt	0	24	''	''	*)	-	-	-	-	*	-
en_4793.txt	0	25	rather	RB	(PP*	-	-	-	-	*	-
en_4793.txt	0	26	than	IN	*	-	-	-	-	*	-
en_4793.txt	0	27	``	``	(NP*	-	-	-	-	*	-
en_4793.txt	0	28	capture	NN	*	-	-	-	-	*	-
en_4793.txt	0	29	''	''	*	-	-	-	-	*	-
en_4793.txt	0	30	market	NN	*	-	-	-	-	*	-
en_4793.txt	0	31	strategy	NN	*))))))))))))	-	-	-	-	*	-
en_4793.txt	0	32	,	,	*	-	-	-	-	*	-
en_4793.txt	0	33	but	CC	*	-	-	-	-	*	-
en_4793.txt	0	34	at	IN	(S(NP(NP(ADVP*	-	-	-	-	*	(15
en_4793.txt	0	35	least	JJS	*)	-	-	-	-	*	-
en_4793.txt	0	36	the	DT	*	-	-	-	-	*	-
en_4793.txt	0	37	issue	NN	*)	-	-	-	-	*	-
en_4793.txt	0	38	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	39	access	NN	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	40	to	TO	(PP*	-	-	-	-	*	-
en_4793.txt	0	41	medicines	NNS	(NP*)))))	-	-	-	-	*	15)
en_4793.txt	0	42	is	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	43	no	RB	(ADVP*	-	-	-	-	*	-
en_4793.txt	0	44	longer	RB	*)	-	-	-	-	*	-
en_4793.txt	0	45	being	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	46	viewed	VBN	(VP*	-	-	-	-	*	-
en_4793.txt	0	47	at	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	48	arm	NNS	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	49	'	POS	*)	-	-	-	-	*	-
en_4793.txt	0	50	s	JJ	*	-	-	-	-	*	-
en_4793.txt	0	51	length	NN	*))))))	-	-	-	-	*	-
en_4793.txt	0	52	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	More	RBR	(TOP(FRAG(X(ADVP*))	-	-	-	-	*	-
en_4793.txt	0	1	needs	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	2	to	TO	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	3	be	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	4	done	VBN	(VP*	-	-	-	-	*	-
en_4793.txt	0	5	on	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	6	the	DT	(NP(NP*	-	-	-	-	*	(15
en_4793.txt	0	7	issue	NN	*)	-	-	-	-	*	-
en_4793.txt	0	8	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	9	IP	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	10	rights	NNS	*)))))))))	-	-	-	-	*	15)
en_4793.txt	0	11	–	SYM	(X*)	-	-	-	-	*	-
en_4793.txt	0	12	the	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	13	sacred	JJ	*	-	-	-	-	*	-
en_4793.txt	0	14	cow	NN	*)	-	-	-	-	*	-
en_4793.txt	0	15	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	16	the	DT	(NP*	-	-	-	-	*	(1
en_4793.txt	0	17	pharmaceutical	JJ	*	-	-	-	-	*	-
en_4793.txt	0	18	industry	NN	*)))	-	-	-	-	*	1)
en_4793.txt	0	19	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Developing-country	NN	(TOP(S(NP*	-	-	-	-	*	-
en_4793.txt	0	1	governments	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	2	continue	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	3	to	TO	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	4	go	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	5	head-to-head	JJ	(ADJP*)	-	-	-	-	*	-
en_4793.txt	0	6	with	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	7	Big	NNP	(NP*	-	-	-	-	*	-
en_4793.txt	0	8	Pharma	NNP	*))	-	-	-	-	*	-
en_4793.txt	0	9	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	10	battles	NNS	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	11	over	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	12	compulsory	JJ	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	13	licensing	NN	*)	-	-	-	-	*	-
en_4793.txt	0	14	and	CC	*	-	-	-	-	*	-
en_4793.txt	0	15	patent	NN	(NP*	-	-	-	-	*	-
en_4793.txt	0	16	legislation	NN	*)))))))))	-	-	-	-	*	-
en_4793.txt	0	17	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	There	EX	(TOP(S(NP*)	-	-	-	-	*	-
en_4793.txt	0	1	is	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	2	serious	JJ	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	3	questioning	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	4	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	5	whether	IN	(SBAR*	-	-	-	-	*	-
en_4793.txt	0	6	IP	NNP	(S(NP*	-	-	-	-	*	-
en_4793.txt	0	7	rights	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	8	are	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	9	actually	RB	(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	10	an	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	11	effective	JJ	*	-	-	-	-	*	-
en_4793.txt	0	12	incentive	NN	*)	-	-	-	-	*	-
en_4793.txt	0	13	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	14	drug	NN	(NP*	-	-	-	-	*	-
en_4793.txt	0	15	development	NN	*)))	-	-	-	-	*	-
en_4793.txt	0	16	,	,	*	-	-	-	-	*	-
en_4793.txt	0	17	especially	RB	(PP(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	18	with	IN	*	-	-	-	-	*	-
en_4793.txt	0	19	respect	NN	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	20	to	TO	(PP*	-	-	-	-	*	-
en_4793.txt	0	21	medicines	NNS	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	22	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_4793.txt	0	23	are	VBP	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	24	relevant	JJ	(ADJP*	-	-	-	-	*	-
en_4793.txt	0	25	to	TO	(PP*	-	-	-	-	*	-
en_4793.txt	0	26	diseases	NNS	(NP(NP*)	-	-	-	-	*	(16
en_4793.txt	0	27	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	28	developing	VBG	(NP*	-	-	-	-	*	-
en_4793.txt	0	29	countries	NNS	*))))))))))))	-	-	-	-	*	16)
en_4793.txt	0	30	,	,	*	-	-	-	-	*	-
en_4793.txt	0	31	given	VBN	(PP*	-	-	-	-	*	-
en_4793.txt	0	32	the	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	33	current	JJ	*	-	-	-	-	*	-
en_4793.txt	0	34	dearth	NN	*)	-	-	-	-	*	-
en_4793.txt	0	35	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	36	Rampamp	NNP	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	37	;	:	*	-	-	-	-	*	-
en_4793.txt	0	38	D	NNP	(NP*)))	-	-	-	-	*	-
en_4793.txt	0	39	into	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	40	these	DT	(NP*	-	-	-	-	*	(16
en_4793.txt	0	41	diseases	NNS	*))))))))))	-	-	-	-	*	16)
en_4793.txt	0	42	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	New	JJ	(TOP(S(NP*	-	-	-	-	*	-
en_4793.txt	0	1	models	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	2	are	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	3	being	VBG	(VP*	-	-	-	-	*	-
en_4793.txt	0	4	tested	VBN	(VP*)))	-	-	-	-	*	-
en_4793.txt	0	5	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	UNITAID	NNP	(TOP(S(NP(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	1	'	POS	*)	-	-	-	-	*	-
en_4793.txt	0	2	s	JJ	*	-	-	-	-	*	-
en_4793.txt	0	3	patent	NN	*	-	-	-	-	*	-
en_4793.txt	0	4	pool	NN	*)	-	-	-	-	*	-
en_4793.txt	0	5	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	6	AIDS	NNP	(NP*	-	-	-	-	*	-
en_4793.txt	0	7	medicines	NNS	*)))	-	-	-	-	*	-
en_4793.txt	0	8	,	,	*	-	-	-	-	*	-
en_4793.txt	0	9	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	10	example	NN	(NP*))	-	-	-	-	*	-
en_4793.txt	0	11	,	,	*	-	-	-	-	*	-
en_4793.txt	0	12	allows	VBZ	(VP*	-	-	-	-	*	-
en_4793.txt	0	13	generics	NNS	(S(NP*	-	-	-	-	*	-
en_4793.txt	0	14	producers	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	15	to	TO	(VP*	-	-	-	-	*	-
en_4793.txt	0	16	make	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	17	cheaper	JJR	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	18	versions	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	19	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	20	patented	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	21	medicines	NNS	*)))	-	-	-	-	*	-
en_4793.txt	0	22	by	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	23	enabling	VBG	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	24	patent	NN	(S(NP*	-	-	-	-	*	(17
en_4793.txt	0	25	holders	NNS	*)	-	-	-	-	*	17)
en_4793.txt	0	26	to	TO	(VP*	-	-	-	-	*	-
en_4793.txt	0	27	license	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	28	their	PRP$	(NP*	-	-	-	-	*	(17)
en_4793.txt	0	29	technology	NN	*)	-	-	-	-	*	-
en_4793.txt	0	30	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	31	exchange	NN	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	32	for	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	33	royalties	NNS	(NP*))))))))))))))	-	-	-	-	*	-
en_4793.txt	0	34	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Ultimately	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_4793.txt	0	1	,	,	*	-	-	-	-	*	-
en_4793.txt	0	2	generics	NNS	(NP*)	-	-	-	-	*	-
en_4793.txt	0	3	remain	VBP	(VP*	-	-	-	-	*	-
en_4793.txt	0	4	the	DT	(NP*	-	-	-	-	*	-
en_4793.txt	0	5	current	JJ	*	-	-	-	-	*	-
en_4793.txt	0	6	front-runner	NN	*)	-	-	-	-	*	-
en_4793.txt	0	7	in	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	8	terms	NNS	(NP(NP*)	-	-	-	-	*	-
en_4793.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	10	delivering	VBG	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	11	affordable	JJ	(NP*	-	-	-	-	*	-
en_4793.txt	0	12	medicines	NNS	*)))))))	-	-	-	-	*	-
en_4793.txt	0	13	.	.	*))	-	-	-	-	*	-

en_4793.txt	0	0	Formulating	NN	(TOP(S(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	1	policies	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	2	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_4793.txt	0	3	enable	VBP	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	4	generic	JJ	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	5	competition	NN	*)	-	-	-	-	*	-
en_4793.txt	0	6	with	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	7	the	DT	(NP*	-	-	-	-	*	(1
en_4793.txt	0	8	branded	JJ	*	-	-	-	-	*	-
en_4793.txt	0	9	pharmaceutical	JJ	*	-	-	-	-	*	-
en_4793.txt	0	10	industry	NN	*)))))))	-	-	-	-	*	1)
en_4793.txt	0	11	will	MD	(VP*	-	-	-	-	*	-
en_4793.txt	0	12	require	VB	(VP*	-	-	-	-	*	-
en_4793.txt	0	13	creative	JJ	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	14	measures	NNS	*)	-	-	-	-	*	-
en_4793.txt	0	15	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_4793.txt	0	16	emphasise	VBP	(S(VP*	-	-	-	-	*	-
en_4793.txt	0	17	the	DT	(NP(NP*	-	-	-	-	*	-
en_4793.txt	0	18	imperative	NN	*)	-	-	-	-	*	-
en_4793.txt	0	19	of	IN	(PP*	-	-	-	-	*	-
en_4793.txt	0	20	maximizing	VBG	(NP*	-	-	-	-	*	-
en_4793.txt	0	21	public	JJ	*	-	-	-	-	*	-
en_4793.txt	0	22	health	NN	*)))))))))	-	-	-	-	*	-
en_4793.txt	0	23	.	.	*))	-	-	-	-	*	-

#end document
